I-Mab Expands its Ongoing Myeloma Clinical Trials of MOR202 to China
I-Mab Biopharma is expanding to mainland China its…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
CHMP Recommends Darzalex Triple Combo for Some Newly Diagnosed Multiple Myeloma Patients in EU
The European Medicines Agency (EMA) has recommended that …
Multiple Myeloma Patients Best Treated at Recognized Care Centers with High Volume, US Study Reports
Multiple myeloma patients treated in their community by…
Xpovio Leads to Promising Responses in Heavily Treated Multiple Myeloma Patients, Phase 2 Trial Shows
Taking Xpovio (selinexor) in combination with the…
Myeloma Crowd Invites Patients to Join Study Investigating Link Between Psoriasis and Myeloma
The Myeloma Crowd is inviting multiple myeloma…
New MMRF Patient Registry Aims to Help Develop Personalized Treatments for Multiple Myeloma
Ultimately aiming to advance precision medicine, the Multiple…
